| |
|
|
|
Aridis Pharmaceuticals Inc  
|
|
7 -0.24 (-0.03%) |
10-27 16:00 |
|
Open: |
7.34 |
Pre close: |
7.24 |
Target:
|
9.09
|
|
High: |
7.7 |
Low: |
6.73 |
Resistance:
|
7.78
8.50
|
|
Volume: |
33,630 |
Market Cap: |
62M |
Support:
|
6.62
5.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.51
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
7.58 |
Signal(12,26,9): |
0.12 |
|
MA(100): |
7.04  |
Stochastic Oscillator |
%K(14,3):
|
29.64 |
|
MA(250): |
6.49 |
%D(3): |
39.78 |
|
Average Volume(K) |
3-Month: |
1252
|
52-Week |
High:
|
10.18 |
|
10-Days: |
2229 |
Low: |
3.80 |
|
RSI |
RSI(14):
|
41.45 |
Change(%): |
31.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.700 |
Return on Equity (ttm) |
-1000.8 |
Shares Out. (M) |
8.92 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-87.8 |
Shares Float (M) |
5.20 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
32.77 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.10 |
|
Forward EPS |
-3.510 |
Gross Profit (p.s.) |
-2.585 |
Shares Short (K) |
6 |
|
Book Value (p.s.) |
-0.680 |
EBITDA (p.s.) |
-2.638 |
P/E |
-2.59 |
|
Sales Per Share |
0.112 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-10.29 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-2.26 |
P/S |
62.44 |
|
Operating Margin |
-2387.00 |
Levered Free Cash Flow
(M) |
1.30 |
P/CF |
-27.63 |
|
|
|
|
|
|
